thank you for an intelligent reply....much appreciated! good information! does the recent new rate have any bearing on credibility for the company (ie: help the potential of national coverage?) or is it all contingent on gold study? Seems like the huge dilution is priced into the this security and that dilution (raise $$) announcement will take that fear off the table (as well as the bk fear that seems to be hanging over this company). seems that even if they no choice but to raise $15M with 100M shares at .15, they would have about 220M outstanding. if they are able to ramp up sales in 2016, a $250M market cap would still be north of $1 per share. with those numbers, seems to be investment potential with this company.
I have only followed this company for a few months. It seems the CMS ruling for 2016 is big deal and provides them credibility. I would like to hear some thoughts on the possibility of BK in the near future. It seems Deerfield is attempting to work with them, but 3 weeks is a short amount of time to come to an agreement. Is there real potential (with the recent CMS ruling) that another pharm would want to partner with them? It seems if they need to raise $$, they would need to do a high number of shares at .10 to even make it worthwhile. can anyone advise if I am missing anything. Is there any potential with this company? thanks for your help!!